A Study to Investigate The Effect of Pimicotinib on The Pharmacokinetics of Metformin, Fexofenadine and Rosuvastatin In Healthy Subjects
Clinical trial NCT06779253 · COMPLETED
Trial details
- NCT number
- NCT06779253
- Sponsor
- Abbisko Therapeutics Co, Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-14
- Primary completion
- 2025-04-04
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.